Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Operating Expenses | 5,613 | 4,662 | 5,683 | 4,635 | 6,652 |
Operating Income | -5,613 | -4,662 | -5,683 | -4,635 | -6,652 |
Other Income | 73 | 37 | 13 | 31 | 53 |
Pre-tax Income | -5,540 | -4,625 | -5,670 | -4,604 | -6,599 |
Net Income Continuous | -5,540 | -4,625 | -5,670 | -4,604 | -6,599 |
Net Income | $-5,540 | $-4,625 | $-5,670 | $-4,604 | $-6,599 |
EPS Basic Total Ops | -0.36 | -0.41 | -0.98 | -0.69 | -1.21 |
EPS Basic Continuous Ops | -0.36 | -0.41 | -0.98 | -0.74 | -1.21 |
EPS Diluted Total Ops | -0.36 | -0.41 | -0.98 | -0.69 | -1.21 |
EPS Diluted Continuous Ops | -0.36 | -0.41 | -0.98 | -0.74 | -1.21 |
EBITDA(a) | $-5,502 | $-4,554 | $-5,575 | $-4,531 | $-6,545 |